FdaApplication
NDA 022503
Identifiers
- fda_app_no: NDA022503
Properties
| Property | Value |
|---|---|
| applicant_name | PRIMUS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2015-06-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METAXALONE | METAXALONE | 640MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product